BiondVax Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BVXV and buy or sell other stocks, ETFs, and their options commission-free!About BVXV
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza.
CEOAmir Reichman, MBA
CEOAmir Reichman, MBA
Employees31
Employees31
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2003
Founded2003
Employees31
Employees31
BVXV Key Statistics
Market cap1.16M
Market cap1.16M
Price-Earnings ratio-0.06
Price-Earnings ratio-0.06
Dividend yield—
Dividend yield—
Average volume76.98K
Average volume76.98K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.18
52 Week high$6.18
52 Week low$0.70
52 Week low$0.70
Stock Snapshot
With a market cap of 1.16M, BiondVax Pharmaceuticals(BVXV) trades at $1.36. The stock has a price-to-earnings ratio of -0.06.
BiondVax Pharmaceuticals(BVXV) stock opened on 2025-12-19 at —. The price climbed to — and dipped to —.
BiondVax Pharmaceuticals(BVXV) shares are trading with a volume of 0, against a daily average of 76.98K.
In the last year, BiondVax Pharmaceuticals(BVXV) shares hit a 52-week high of $6.18 and a 52-week low of $0.70.
In the last year, BiondVax Pharmaceuticals(BVXV) shares hit a 52-week high of $6.18 and a 52-week low of $0.70.